Avacta Group Plc (LON:AVCT – Get Rating) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 128.03 ($1.59) and traded as low as GBX 106 ($1.32). Avacta Group shares last traded at GBX 108.50 ($1.35), with a volume of 508,969 shares.
Avacta Group Trading Down 0.3 %
The business’s 50 day moving average price is GBX 120.11 and its 200-day moving average price is GBX 128.03. The company has a current ratio of 0.82, a quick ratio of 4.96 and a debt-to-equity ratio of 341.38. The company has a market cap of £297.93 million, a price-to-earnings ratio of -723.33 and a beta of 1.50.
Avacta Group Company Profile
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays.
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.